IHS Chemical Week

EnviroTech :: R&D

GSK to Build Its First Pharmaceutical Plant in U.K. for 40 Years

6:53 AM MDT | March 22, 2012 | Alex Scott

GlaxoSmithKline has confirmed plans outlined first in November 2010 that it will invest more than £500 million ($790 million) in R&D and manufacturing in the U.K. From the £500 million, GSK will invest £350 million to build a new biopharmaceutical manufacturing facility at its site at Ulverston, U.K. It will be GSK’s first new manufacturing site in the U.K. for 40 years. Also from the £500 million, the company will invest £100 million in its existing manufacturing operations at Montrose and Irvine, U.K. GSK will invest the...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa